Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An embarrassment of riches: An update on the symptomatic treatment of canine atopic dermatitis.

× No keyword cloud information.

15 in total

1. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.

Authors: Sallie B Cosgrove; Dawn M Cleaver; Vickie L King; Amy R Gilmer; Anne E Daniels; Jody A Wren; Michael R Stegemann
Journal: Vet Dermatol Date: 2015-02-16 Impact factor: 1.589

2. Vaccination against IL-31 for the treatment of atopic dermatitis in dogs.

Authors: Martin F Bachmann; Andris Zeltins; Gints Kalnins; Ina Balke; Nina Fischer; Ana Rostaher; Kaspars Tars; Claude Favrot
Journal: J Allergy Clin Immunol Date: 2018-04-04 Impact factor: 10.793

3. A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.

Authors: Gina M Michels; Kelly F Walsh; Kristina A Kryda; Sean P Mahabir; Rodney R Walters; Jacquelien D Hoevers; Olivier M Martinon
Journal: Vet Dermatol Date: 2016-09-19 Impact factor: 1.589

4. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.

Authors: Gina M Michels; Deborah S Ramsey; Kelly F Walsh; Olivier M Martinon; Sean P Mahabir; Jacquelien D Hoevers; Rodney R Walters; Steven A Dunham
Journal: Vet Dermatol Date: 2016-09-19 Impact factor: 1.589

5. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.

Authors: Tim J Nuttall; Neil A McEwan; Emmanuel Bensignor; Luisa Cornegliani; Christine Löwenstein; Christophe A Rème
Journal: Vet Dermatol Date: 2011-07-01 Impact factor: 1.589

6. A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.

Authors: Hilde Moyaert; Leen Van Brussel; Stasia Borowski; Monica Escalada; Sean P Mahabir; Rodney R Walters; Michael R Stegemann
Journal: Vet Dermatol Date: 2017-09-14 Impact factor: 1.589

7. Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study.

Authors: Ana M Lourenço; Vanessa Schmidt; Berta São Braz; Diana Nóbrega; Telmo Nunes; José H Duarte-Correia; Daniela Matias; Emi Maruhashi; Christophe A Rème; Tim Nuttall
Journal: Vet Dermatol Date: 2016-01-25 Impact factor: 1.589

Review 8. Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.

Authors: Tim Nuttall; Douglas Reece; Elizabeth Roberts
Journal: Vet Rec Date: 2014-03 Impact factor: 2.695

9. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.

Authors: Peter R Little; Vickie L King; Kylie R Davis; Sallie B Cosgrove; Michael R Stegemann
Journal: Vet Dermatol Date: 2014-12-12 Impact factor: 1.589

10. Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks.

Authors: Alessandro Panteri; Günther Strehlau; Rainer Helbig; Christine Prost; Kelly Doucette
Journal: Vet Dermatol Date: 2015-12-11 Impact factor: 1.589

1 in total

1. West Highland White Terriers under primary veterinary care in the UK in 2016: demography, mortality and disorders.

Authors: Dan G O'Neill; Zoie F Ballantyne; Anke Hendricks; David B Church; Dave C Brodbelt; Camilla Pegram
Journal: Canine Genet Epidemiol Date: 2019-09-03

1 in total